FS120 Phase 1/1b Study in Patients With Advanced Malignancies
FS120 Phase 1/1b Study in Patients With Advanced Malignancies
Active, not recruiting · NCT04648202 · Registry updated 2025-06-27Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| FS120 Phase 1/1b Study in Patients With Advanced Malignancies | Neoplasm Metastasis, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, metastatic malignant neoplasm, neoplasm | Active, not recruiting | Phase 1 | 2025-06-27 | NCT04648202 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| invoX Pharma Limited | 2 |
| Merck Sharp & Dohme LLC | 650 |
9 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Hospital Clinico Universitario de Valencia | Valencia | Spain | 109 |
| Hospital Universitario 12 de Octubre | Madrid | Spain | 359 |
| Hospital Universitario Fundacion Jimenez Diaz | Madrid | Spain | 63 |
| Hospital Universitario Vall D'Hebron | Barcelona | Spain | 86 |
| Huntsman Cancer Institute, University of Utah | Salt Lake City | United States | 45 |
| MD Anderson Cancer Center | Houston | United States | 589 |
| NEXT Oncology, Hospital Quironsalud Barcelona | Barcelona | Spain | 1 |
| South Texas Accelerated Research Therapeutics (START) | San Antonio | United States | 8 |
| Yale University | New Haven | United States | 44 |